These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7442606)

  • 21. [REFERENCE RANGES OF ANTITHROMBINE III IN ASSOCIATION WITH THE USE OF A STA COMPACT AUTOMATED COAGULOMETER].
    Petrova OV; Urtaeva ZA; Gordeeva OB; Shashin SA; Tarasov DG
    Klin Med (Mosk); 2015; 93(10):43-6. PubMed ID: 26964465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recommendations for initial diagnosis and therapy in acute blood coagulation disorders].
    Sütterlin R; Barthels D
    Anaesthesiol Reanim; 1996; 21(3):76-80. PubMed ID: 8766399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation abnormalities in diabetic patients undergoing renal transplantation.
    Reissell E; Lalla M; Höckerstedt K; Lindgren L
    Ann Chir Gynaecol; 1994; 83(3):251-5. PubMed ID: 7857071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of antithrombin deficiencies.
    Mammen EF
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):2-6; discussion 7. PubMed ID: 8821204
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of antithrombin III in coagulation disorders: state-of-the-art review. Proceedings of a symposium. Boston, Massachusetts, September 16 to 18, 1988.
    Am J Med; 1989 Sep; 87(3B):1S-67S. PubMed ID: 2679065
    [No Abstract]   [Full Text] [Related]  

  • 26. Proteases and antiproteases in ascites--differentiation of malignant and nonmalignant ascites and prediction of coagulopathy in ascites retransfusion.
    Schölmerich J; Köttgen E; Volk BA; Gerok W
    Adv Exp Med Biol; 1988; 240():555-60. PubMed ID: 3072859
    [No Abstract]   [Full Text] [Related]  

  • 27. Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria: a laboratory finding unrelated to intravascular coagulopathy.
    Fujii K; Usuki A; Kan-No Y; Ohgou N
    J Dermatol; 2008 May; 35(5):308-10. PubMed ID: 18477235
    [No Abstract]   [Full Text] [Related]  

  • 28. Diphasic increase in thrombin-antithrombin III complex in blood from the internal jugular vein following severe head injury.
    Suzuki M; Motohashi O; Nishino A; Shiina V; Mizoi K; Yoshimoto T; Kameyama M; Onuma T
    Thromb Haemost; 1994 Jan; 71(1):155-7. PubMed ID: 8165638
    [No Abstract]   [Full Text] [Related]  

  • 29. Do coagulation abnormalities contribute to sepsis associated organ failure?
    Abraham E
    Crit Care Med; 2006 Jun; 34(6):1842-4. PubMed ID: 16714997
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.
    Pryor JA; Cooper KR; Bass JD; Hampton HL; Rock WA; Morrison JC
    J Miss State Med Assoc; 1996 Oct; 37(10):777-9. PubMed ID: 8908950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin III, protein S, and coagulation in the nephrotic syndrome.
    Schnaper HW
    Pediatr Nephrol; 2001 Jan; 16(1):98. PubMed ID: 11198616
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemostatic disorders as a complication of autoimmune hemolytic anemia in dogs].
    Mischke R
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):13-6. PubMed ID: 9499627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activity of antithrombin III in the blood of patients with bladder cancer].
    Zietek Z; Iwan-Zietek I; Kotschy M; Wiśniewska E; Tyloch F
    Pol Merkur Lekarski; 1997 Apr; 2(10):268-9. PubMed ID: 9377663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation disorders after reperfusion of pancreatic allografts.
    Nader A; Büsing M; Blumenstock I; Heimburger N; Jochum M; Hopt UT
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1174-5. PubMed ID: 8442077
    [No Abstract]   [Full Text] [Related]  

  • 36. [Plasma fibronectin in acute myeloid leukemia].
    García Frade LJ; García Avello A; Obispo T; Alava I; Odriozola J; Cesar J; Pardo A; Navarro JL
    Sangre (Barc); 1984; 29(4-A):376-83. PubMed ID: 6594781
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of coagulation disorders and cancer procoagulant activity in patients with myelodysplastic syndromes.
    Chojnowski K; Treliński J; Wawrzyniak E; Sobolewska M; Mielicki W
    Neoplasma; 2002; 49(3):155-8. PubMed ID: 12098000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies of antithrombin III assay using new chromogenic peptide substrates (author's transl)].
    Asai K; Takagi A; Inagaki Y; Setsuda Y
    Rinsho Byori; 1979 Dec; 27(12):1121-5. PubMed ID: 541858
    [No Abstract]   [Full Text] [Related]  

  • 39. Detecting antithrombin deficiency may be a difficult task--more than one test is necessary.
    Kristensen SR; Rasmussen B; Pedersen S; Bathum L
    J Thromb Haemost; 2007 Mar; 5(3):617-8. PubMed ID: 17229050
    [No Abstract]   [Full Text] [Related]  

  • 40. Automation of antithrombin III methods on routinely available instruments.
    Conard J
    Semin Thromb Hemost; 1983 Oct; 9(4):263-7. PubMed ID: 6658460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.